ArticleDrugs - real world outcomes2020

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study.

Nestor Szerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.